PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 22704779-0 2013 Different effects of catechin on angiogenesis and inflammation depending on VEGF levels. Catechin 21-29 vascular endothelial growth factor A Homo sapiens 76-80 24847951-0 2015 Catechins inhibit vascular endothelial growth factor production and cyclooxygenase-2 expression in human dental pulp cells. Catechin 0-9 vascular endothelial growth factor A Homo sapiens 18-52 22704779-5 2013 Catechin modulation of angiogenesis and inflammation was also evaluated in vivo using different models of angiogenesis: one physiological (skin wound-healing assay) and another one resembling pathological angiogenesis, exhibiting higher vascular endothelial growth factor (VEGF)-A stimulation (Matrigel plug assay). Catechin 0-8 vascular endothelial growth factor A Homo sapiens 237-271 22704779-5 2013 Catechin modulation of angiogenesis and inflammation was also evaluated in vivo using different models of angiogenesis: one physiological (skin wound-healing assay) and another one resembling pathological angiogenesis, exhibiting higher vascular endothelial growth factor (VEGF)-A stimulation (Matrigel plug assay). Catechin 0-8 vascular endothelial growth factor A Homo sapiens 273-277 22704779-10 2013 Altogether, the current study showed that catechin has different effects in angiogenesis and inflammation depending on VEGF-A levels. Catechin 42-50 vascular endothelial growth factor A Homo sapiens 119-125 17384142-6 2007 The selective nitration inhibitor epicatechin enhanced VEGF"s angiogenic function in activating VEGFR2, c-Src, and promoting endothelial cell growth, migration, and tube formation in vitro and retinal neovascularization in vivo. Catechin 34-45 vascular endothelial growth factor A Homo sapiens 55-59 17574044-12 2007 In combination, catechin and IP6 amplified VEGF reduction compared to each agent in MIAPACA and control (P < 0.002). Catechin 16-24 vascular endothelial growth factor A Homo sapiens 43-47 17016658-3 2006 In this study, we investigated the effect of epigallocatechin-3-gallate (EGCG), the major green tea catechin, on the PDGF-induced VEGF expression in hVSMCs and the underlying mechanisms. Catechin 53-61 vascular endothelial growth factor A Homo sapiens 130-134 12175544-0 2002 Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding. Catechin 4-13 vascular endothelial growth factor A Homo sapiens 140-144 16217757-0 2006 Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Catechin 10-18 vascular endothelial growth factor A Homo sapiens 57-91 16217757-2 2006 We have shown previously that the green tea catechin, epigallocatechin gallate (EGCG), inhibits endothelial cell tube formation through the inhibition of vascular endothelial growth factor (VEGF)-induced Akt activation and vascular endothelial (VE)-cadherin phosphorylation. Catechin 44-52 vascular endothelial growth factor A Homo sapiens 154-188 16217757-2 2006 We have shown previously that the green tea catechin, epigallocatechin gallate (EGCG), inhibits endothelial cell tube formation through the inhibition of vascular endothelial growth factor (VEGF)-induced Akt activation and vascular endothelial (VE)-cadherin phosphorylation. Catechin 44-52 vascular endothelial growth factor A Homo sapiens 190-194 14604298-8 2003 They can inhibit VEGF formation (as used in cerebral oedema dexamethason, or barbiturates, trichstatin A, candesartan, small molecule inhibitors of hypoxia-inducible factor 1, gelandamycin, antysenses, rybosymes and catechins) or VEGF activity (soluble receptors, monoclonal antibodies, heterodimeric antagonistic VEGF variant, RTK inhibitors and catechins). Catechin 216-225 vascular endothelial growth factor A Homo sapiens 17-21 14604298-8 2003 They can inhibit VEGF formation (as used in cerebral oedema dexamethason, or barbiturates, trichstatin A, candesartan, small molecule inhibitors of hypoxia-inducible factor 1, gelandamycin, antysenses, rybosymes and catechins) or VEGF activity (soluble receptors, monoclonal antibodies, heterodimeric antagonistic VEGF variant, RTK inhibitors and catechins). Catechin 347-356 vascular endothelial growth factor A Homo sapiens 17-21 12918064-0 2003 Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule. Catechin 10-19 vascular endothelial growth factor A Homo sapiens 28-32 12918064-6 2003 Using tube formation of human microvascular endothelial cells (HMVEC) in culture as an in vitro model of angiogenesis, we reported that vascular endothelial growth factor (VEGF)-induced tube formation is inhibited by anti-VE-cadherin antibody and dose-dependently by green tea catechins. Catechin 277-286 vascular endothelial growth factor A Homo sapiens 136-170 12918064-6 2003 Using tube formation of human microvascular endothelial cells (HMVEC) in culture as an in vitro model of angiogenesis, we reported that vascular endothelial growth factor (VEGF)-induced tube formation is inhibited by anti-VE-cadherin antibody and dose-dependently by green tea catechins. Catechin 277-286 vascular endothelial growth factor A Homo sapiens 172-176 12175544-5 2002 When these four catechins were tested on VEGF binding assay, only EGCg inhibited the binding of VEGF, a major angiogenesis inducing factor, to endothelial cells in a concentration dependent manner. Catechin 16-25 vascular endothelial growth factor A Homo sapiens 96-100 35568144-0 2022 Structurally related (-)-epicatechin metabolites and gut microbiota derived metabolites exert genomic modifications via VEGF signaling pathways in brain microvascular endothelial cells under lipotoxic conditions: Integrated multi-omic study. Catechin 25-36 vascular endothelial growth factor A Homo sapiens 120-124 34121550-0 2022 Catechin Metabolites along with Curcumin Inhibit Proliferation and Induce Apoptosis in Cervical Cancer Cells by Regulating VEGF Expression In-Vitro. Catechin 0-8 vascular endothelial growth factor A Homo sapiens 123-127 34121550-8 2022 Results showed that catechin metabolites along with curcumin reduce the VEGF expression. Catechin 20-28 vascular endothelial growth factor A Homo sapiens 72-76